Lucigenin chemiluminescence in human seminal plasma.
Seminal plasma protects spermatozoa from the detrimental effects of reactive oxygen species such as hydrogen peroxide. We investigated the lucigenin-dependent chemiluminescence in cell-free seminal plasma from andrological patients. The seminal plasma was separated from cells by centrifugation. In all seminal plasmas studied lucigenin-dependent chemiluminescence (LCL) was detected. The LCL showed a strong pH-dependence. The signal was stable if samples were stored at +4 degrees C for up to 4 days or up to 8 days at -80 degrees C. Filtration of the samples (0.45 and 0.22 microm pore size) did not lower their luminescence. The addition of superoxide dismutase (SOD) and ascorbic acid oxidase (AAO) lowered LCL nearly to baseline values while trolox and desferal showed moderate effect, whereas allopurinol had no effect. Electron paramagnetic resonance spectroscopy demonstrated ascorbyl radicals in seminal plasma. Physiological concentrations of ascorbic acid yielded SOD-inhibitable lucigenin-chemiluminescence. The nitroblue-tetrazolium assay showed that ascorbic acid in buffer solution produced formazan. Superoxide-anion radicals were not detected in seminal plasma by the spin-trap DEPMPO due to their low steady state concentration. It is concluded that in seminal plasma ascorbate reacts with molecular oxygen yielding ascorbyl radicals and superoxide anion. If lucigenin is added to seminal plasma, reducing substances present, such as ascorbate, reduce lucigenin to the corresponding radical; this radical reacts with molecular oxygen and also forms O2-. So LCL in human seminal plasma results from the autoxidation of ascorbate and the oxidation of the reduced lucigenin. While the physiological relevance of the former mechanism is unknown, the latter is an artifact.
Department of Dermatology, Klinikum J.W. Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt/M, Germany. ochsendorf@em.uni-frankfurt.de
F R
FR
Ochsendorf
C
C
Goy
J
J
Fuchs
W
W
Mörke
H A
HA
Beschmann
H J
HJ
Brömme
D000166:Acridines / Q000032:analysis*; D000328:Adult; D000493:Allopurinol / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D001204:Ascorbate Oxidase / Q000494:pharmacology; D001205:Ascorbic Acid / Q000378:metabolism*; D002839:Chromans / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004578:Electron Spin Resonance Spectroscopy; D005609:Free Radicals; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007248:Infertility, Male / Q000378:metabolism*; D008163:Luminescent Measurements; D008297:Male; D016877:Oxidants / Q000494:pharmacology; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D010101:Oxygen Consumption; D017382:Reactive Oxygen Species; D012661:Semen / Q000737:chemistry*; D012662:Semen Preservation; D013482:Superoxide Dismutase / Q000494:pharmacology; D013696:Temperature
D000166:Acridines; D000975:Antioxidants; D002839:Chromans; D005609:Free Radicals; D016877:Oxidants; D017382:Reactive Oxygen Species; C033472:10,10'-dimethyl-9,9'-biacridinium; D000493:Allopurinol; D001204:Ascorbate Oxidase; D013482:Superoxide Dismutase; D003676:Deferoxamine; D001205:Ascorbic Acid; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; D010100:Oxygen